PRELUDE CAPITAL MANAGEMENT, LLC

Position in INGN — Inogen Inc

CIK 1387508 NEW YORK, NY

Position in INGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$94,544

-$5,930 QoQ

Shares Held

14,658

-9.8% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#77

of 128 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $16,970,515 across 13 Medical Devices names. INGN ranks #12 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	36,381	$11,487,300
2			115,133	$2,864,509
3	BIO	Bio-Rad Laboratories, Inc.	2,015	$591,624
4	TNDM	Tandem Diabetes Care Inc	19,002	$286,740
5	DXCM	Dexcom Inc	3,857	$259,768
6	RXST	RxSight, Inc.	51,600	$248,712
7	BVS	Bioventus Inc.	25,780	$243,363
8	VREX	Varex Imaging Corp	23,254	$242,539

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$94,544	14,658	-9.8%	Shares	Other	2026-08-14
2026-03-31	$100,474	16,258	+28.4%	Shares	Other	2026-05-15
2025-12-31	$85,061	12,658	+25.9%	Shares	Other	2026-02-17
2025-09-30	$82,173	10,058	-17.9%	Shares	Other	2025-11-14
2024-12-31	$112,314	12,248	-4.3%	Shares	Other	2025-02-14
2024-09-30	$124,121	12,796	-17.2%	Shares	Other	2024-11-14
2024-06-30	$125,689	15,460	-7.4%	Shares	Other	2024-08-14
2024-03-31	$134,664	16,687	-74.1%	Shares	Other	2024-05-15
2023-12-31	$354,236	64,524	+97.3%	Shares	Other	2024-02-14
2023-09-30	$170,694	32,700	+176.7%	Shares	Other	2023-11-14
2023-06-30	$136,486	11,817	+763.2%	Shares	Other	2023-08-14
2020-09-30	$39,701	1,369	+40.1%	Shares	Other	2020-11-16
2020-06-30	$34,703	977	-17.0%	Shares	Other	2020-08-14
2020-03-31	$60,803	1,177	—	Shares	Other	2020-05-15
No filing history on record for this holder in this stock.